What is the financial state of Oramed Pharmaceuticlas (ORMP) in terms of liquidity, solvency and profitiability?

ORAMED PHARMACEUTICALS INC. CONSOLIDATED BALANCE SHEETS U.S. Dollars in thousands (except share and per share data) August 31, 2019 2018 ASSETS $ $ CURRENT ASSETS: Cash and cash equivalents Short-term deposits (note 2) Marketable securities (note 3) Prepaid expenses and other current assets Total current assets 3.329 25,252 3,701 1,042 33,324 4,996 20,875 4,592 574 31,037 LONG-TERM ASSETS: Long-term deposits and investment (note 4) Marketable securities (note 3) Amounts funded in respect of employee rights upon retirement Property and equipment, net Total long-term assets Total assets 1 1,295 19 24 1.339 34,663 13,542 2,785 16 17 16,360 47,397 $ $ LIABILITIES AND STOCKHOLDERS' EQUITY $ $ CURRENT LIABILITIES: Accounts payable and accrued expenses (note 5) Deferred revenues Payable to related parties (note 11c) Total current liabilities 2,541 2,703 64 5,308 2,058 2,449 46 4,553 LONG-TERM LIABILITIES: Deferred revenues Employee rights upon retirement Provision for uncertain tax position (note 10f) Other liabilities Total long-term liabilities 9,658 22 11 271 9,962 11,388 20 11 313 11,732 COMMITMENTS (note 6) 208 100,288 STOCKHOLDERS' EQUITY: Common stock, $ 0.012 par value (30,000,000 authorized shares as of August 31, 2019 and 2018; 17,383,359 and 17,369,875 shares issued and outstanding as of August 31, 2019 and 2018, respectively) Additional paid-in capital Accumulated other comprehensive income Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity 207 99,426 702 (69,223) (81,103) 19,393 31,112 $ 34,663 47,397